These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35864062)

  • 1. A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
    Huang Y; Jiang J; Ren J; Guo Y; Zhao Q; Zhou J; Li Y; Chen R
    Adv Healthc Mater; 2022 Oct; 11(19):e2201265. PubMed ID: 35864062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.
    Huang Y; Gu B; Salles-Crawley II; Taylor KA; Yu L; Ren J; Liu X; Emerson M; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
    Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
    Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
    J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
    Absar S; Nahar K; Kwon YM; Ahsan F
    Pharm Res; 2013 Jun; 30(6):1663-76. PubMed ID: 23468049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.
    Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y
    Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen binding to activated platelets and its biomimetic thrombus-targeted thrombolytic strategies.
    Huang Y; Wang J; Guo Y; Shen L; Li Y
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133286. PubMed ID: 38908635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective binding of cationic fibrinogen-mimicking chitosan nanoparticles to activated platelets and efficient drug release for antithrombotic therapy.
    Huang Y; Wang J; Guo Y; Park SY; Yang H; Lu A; Li Y; Chen R
    Int J Biol Macromol; 2024 May; 268(Pt 1):131742. PubMed ID: 38653430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.
    Hua X; Zhou L; Liu P; He Y; Tan K; Chen Q; Gao Y; Gao Y
    J Thromb Thrombolysis; 2014 Jul; 38(1):57-64. PubMed ID: 24671732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic Modeling of Thrombolysis.
    Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery under cover of erythrocytes extends drug half-life: A thrombolytic targeting therapy utilizing microenvironment-responsive artificial polysaccharide microvesicles.
    Shan L; Wang J; Tu H; Zhang W; Li H; Slezak P; Lu F; Lee D; Hu E; Geng Z; Lan G; Xie R
    Carbohydr Polym; 2024 Nov; 343():122505. PubMed ID: 39174110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis.
    Absar S; Kwon YM; Ahsan F
    J Control Release; 2014 Mar; 177():42-50. PubMed ID: 24417965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection.
    Yu W; Yin N; Yang Y; Xuan C; Liu X; Liu W; Zhang Z; Zhang K; Liu J; Shi J
    Acta Biomater; 2022 Mar; 140():625-640. PubMed ID: 34902617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in stent and vascular graft thrombosis and enhancement of thrombolysis by recombinant Lys-plasminogen in nonhuman primates.
    Sundell IB; Marzec UM; Kelly AB; Chronos NA; Petersen LC; Hanson SR; Hedner U; Harker LA
    Circulation; 1997 Aug; 96(3):941-8. PubMed ID: 9264505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
    van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
    Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
    Maksimenko AV; Tischenko EG
    J Thromb Thrombolysis; 1999 Jun; 7(3):307-12. PubMed ID: 10373713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Sphingosine 1-Phosphate Receptor 1 Modulation Augments Thrombolysis of Low-Dose Tissue Plasminogen Activator Following Cerebrovascular Thrombosis.
    Li HD; Li R; Kong Y; Zhang W; Qi C; Wang D; Hao H; Liu Q
    Front Immunol; 2022; 13():801727. PubMed ID: 35720286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster.
    Matsuno H; Kozawa O; Niwa M; Ito T; Tanabe K; Nishida M; Hayashi H; Uematsu T
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):191-7. PubMed ID: 9700979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser thrombolysis and in vitro release kinetics of tPA encapsulated in chitosan polysulfate-coated nanoliposome.
    Ahmaditabar P; Mahmoodi M; Taheri RA; Asefnejad A
    Carbohydr Polym; 2023 Jan; 299():120225. PubMed ID: 36876826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease.
    Quan X; Liang X; Ding Y; Han Y; Li J; Yuan M; Li Y; Yuan Z; Wang R; Zhao Y
    ACS Nano; 2023 Apr; 17(7):6519-6533. PubMed ID: 36971410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.